InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,162.80
(
0.60%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.16
(
0.01%
)
Bitcoin
64,217.29
(
-0.41%
)
Post# of 1644
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oatsuzn

Send PM Follow Ignore
Followers 22
Posts 1099
Boards Moderated 0
Alias Born 04/05/2016

oatsuzn

Re: None

Monday, 02/27/2017 10:58:48 AM

Monday, February 27, 2017 10:58:48 AM

Post# of 1644
Aphria owns 4.8% of Kalytera Therapeutics Inc.(QUEZF), after additional investment.

http://m.marketwired.com/press-release/aphria-announces-closing-of-bought-deal-financing-2198440.htm

Additional investment in Kalytera Therapeutics, Inc.

The Company also announces that, on February 7, 2017, the Company acquired 2,222,000 common shares of Kalytera Therapeutics, Inc. ("Kalytera") at a price of $0.45 per share, for an aggregate purchase price of $999,900. This transaction was part of Kalytera's private placement announced on January 23, 2017. Further, on February 21, 2017, the Company purchased an additional 1,450,000 common shares of Kalytera on the secondary market. As of today's date, the Company owns 6,172,000 common shares in Kalytera, representing approximately 4.8% of their issued and outstanding shares.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up